Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Jorge Luis Galeano Niño, MD, PhD
In colorectal cancer (CRC), malignant cells are surrounded by a complex microenvironment encompassing a range of non-transformed… -
CRI Funded Scientist
Brianna Duncan-Lowey, PhD
One of the key risk factors for colorectal cancer is inflammatory bowel disease, like Crohn’s disease and… -
CRI Funded Scientist
Merve Deniz Abdusselamoglu, PhD
To be able to combat cancer, we need to better understand how tumors progress from healthy tissues… -
CRI Funded Scientist
Claire L. McIntyre, PhD
Obesity is predicted to overtake smoking as the leading preventable cause of cancer. Yet a recent survey… -
CRI Funded Scientist
Sara Martina Parigi, PhD
Cancers develop when cells in our body acquire mutations and undergo aberrant and uncontrolled proliferation. Our immune… -
CRI Funded Scientist
Guoliang Cui, PhD
The traditional functions of skeletal muscles include their capacity to provide mechanical force, stabilize joints, and regulate glucose and… -
CRI Funded Scientist
Peter E. Fecci, MD, PhD
Brain cancer is notoriously resistant to current immunotherapies, partially due to the “immune privilege” granted by the blood-brain… -
CRI Funded Scientist
David R. Glass, PhD
Cutaneous T cell lymphoma (CTCL) is a skin cancer with limited treatments and poor survival rates. Anti-PD-1… -
CRI Funded Scientist
Malay Haldar, MD, PhD
Understanding the mechanisms driving cancer’s ability to adapt and avoid the immune system is key for cancer immunotherapy….
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.